Miral Invests AED 12 billion to Shape the Next Phase of Yas Island's Growth
A robust five-year pipeline of new developments and enhancements will expand world-class attractions, grow hotel capacity, and further strengthen Yas Island's global appeal ABU DHABI, UAE, Sept. 14, 2026 /PRNewswire/ -- Miral, Abu Dhabi's leading...
Wuhan is really something
WUHAN, China, Sept. 14, 2026 /PRNewswire/ -- On Sept. 14, the bilingual investment promotion film "Wuhan is Really Something" was officially released, a joint production by Wuhan Municipal Investment Promotion Bureau (Wuhan Municipal Administration...
Temporal Raises $550 Million in Series E Round: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE...
IC Ecosystem Show (ICES) 2026 to Drive Application-Led Innovation at CIIF in Shanghai
SHANGHAI, Sept. 11, 2026 /PRNewswire/ -- The IC Ecosystem Show (ICES 2026), one of the flagship theme shows of the 26th China International Industry Fair (CIIF 2026), is officially scheduled to take place from October 12 to 16, 2026, in Hall 5.2 at...
SleepRes Receives Frost & Sullivan's 2026 North America New Product Innovation Recognition for Excellence in Positive Airway Pressure Device Innovation
Advancing patient-centric innovation and next-generation therapy delivery in positive airway pressure devices through clinically validated multi-mode technology and enhanced comfort performance SAN ANTONIO, Sept. 14, 2026 /PRNewswire/ -- Frost &...
Global Fan Enthusiasm Propels 'Lord of Mysteries' into a New Phase of International Growth
NEW YORK, Sept. 14, 2026 /PRNewswire/ -- From web novel to acclaimed animation, Yuewen's celebrated intellectual property (IP) "Lord of Mysteries", continues to captivate audiences worldwide, emerging as one of the most influential Chinese original...
Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
Enabled by Altruist's integrated CMC development platform, GMP manufacturing and regulatory service capabilities, LP-003 has successfully advanced from concept to potential commercialization. LP-003 is the first innovative drug independently...
NEXTBIOMEDICAL Marks Its Largest-Ever Presence at CIRSE 2026 with Exhibition Booth and Learning Center, Highlighting Global Clinical Evidence
SEOUL, South Korea, Sept. 14, 2026 /PRNewswire/ -- NEXTBIOMEDICAL, a medical device company specializing in innovative therapeutic solutions, participated in CIRSE 2026, the annual congress of the Cardiovascular and Interventional Radiological...